279 related articles for article (PubMed ID: 26599299)
21. Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces.
Sasaki A; Arawaka S; Sato H; Kato T
Sci Rep; 2015 Sep; 5():14211. PubMed ID: 26381815
[TBL] [Abstract][Full Text] [Related]
22. Oral administration of rotenone using a gavage and image analysis of alpha-synuclein inclusions in the enteric nervous system.
Pan-Montojo FJ; Funk RH
J Vis Exp; 2010 Oct; (44):. PubMed ID: 21085094
[TBL] [Abstract][Full Text] [Related]
23. Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice.
Naudet N; Antier E; Gaillard D; Morignat E; Lakhdar L; Baron T; Bencsik A
J Neuropathol Exp Neurol; 2017 Dec; 76(12):1046-1057. PubMed ID: 29040593
[TBL] [Abstract][Full Text] [Related]
24. The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
Shannon K; Vanden Berghe P
Cell Tissue Res; 2018 Jul; 373(1):313-326. PubMed ID: 29936550
[TBL] [Abstract][Full Text] [Related]
25. Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.
Malek N; Swallow D; Grosset KA; Anichtchik O; Spillantini M; Grosset DG
Acta Neurol Scand; 2014 Aug; 130(2):59-72. PubMed ID: 24702516
[TBL] [Abstract][Full Text] [Related]
26. Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.
Del Tredici K; Braak H
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):33-50. PubMed ID: 26662475
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.
Lionnet A; Wade MA; Corbillé AG; Prigent A; Paillusson S; Tasselli M; Gonzales J; Durieu E; Rolli-Derkinderen M; Coron E; Duchalais E; Neunlist M; Perkinton MS; Hanger DP; Noble W; Derkinderen P
Acta Neuropathol Commun; 2018 Jul; 6(1):65. PubMed ID: 30037345
[TBL] [Abstract][Full Text] [Related]
28. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification.
Fenyi A; Leclair-Visonneau L; Clairembault T; Coron E; Neunlist M; Melki R; Derkinderen P; Bousset L
Neurobiol Dis; 2019 Sep; 129():38-43. PubMed ID: 31078683
[TBL] [Abstract][Full Text] [Related]
29. Prion-like propagation of α-synuclein in the gut-brain axis.
Chen Y; Shao Q; Yuan YH; Chen NH
Brain Res Bull; 2018 Jun; 140():341-346. PubMed ID: 29894766
[TBL] [Abstract][Full Text] [Related]
30. [Autonomic nervous system as a source of biomarkers in Parkinson's disease].
Pouclet H; Lebouvier T; Flamant M; Coron E; Neunlist M; Derkinderen P; Rouaud T
Presse Med; 2012 Jul; 41(7-8):695-701. PubMed ID: 22284542
[TBL] [Abstract][Full Text] [Related]
31. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients.
Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W
Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383
[TBL] [Abstract][Full Text] [Related]
32. Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?
Ruffmann C; Parkkinen L
Mov Disord; 2016 Feb; 31(2):193-202. PubMed ID: 26799450
[TBL] [Abstract][Full Text] [Related]
33. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
Arotcarena ML; Dovero S; Prigent A; Bourdenx M; Camus S; Porras G; Thiolat ML; Tasselli M; Aubert P; Kruse N; Mollenhauer B; Trigo Damas I; Estrada C; Garcia-Carrillo N; Vaikath NN; El-Agnaf OMA; Herrero MT; Vila M; Obeso JA; Derkinderen P; Dehay B; Bezard E
Brain; 2020 May; 143(5):1462-1475. PubMed ID: 32380543
[TBL] [Abstract][Full Text] [Related]
34. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
[TBL] [Abstract][Full Text] [Related]
35. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
36. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
Anis E; Xie A; Brundin L; Brundin P
Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
[TBL] [Abstract][Full Text] [Related]
37. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
38. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease.
Michell AW; Luheshi LM; Barker RA
Neurosci Lett; 2005 Jun; 381(3):294-8. PubMed ID: 15896487
[TBL] [Abstract][Full Text] [Related]
39. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.
Pan-Montojo F; Schwarz M; Winkler C; Arnhold M; O'Sullivan GA; Pal A; Said J; Marsico G; Verbavatz JM; Rodrigo-Angulo M; Gille G; Funk RH; Reichmann H
Sci Rep; 2012; 2():898. PubMed ID: 23205266
[TBL] [Abstract][Full Text] [Related]
40. α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon.
Swaminathan M; Fung C; Finkelstein DI; Bornstein JC; Foong JPP
Neuroscience; 2019 Dec; 423():76-85. PubMed ID: 31705886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
